Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moderna, Inc. MRNA

Healthcare  —  Biotechnology
198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
S&P 500 Member
Indexes indicate stock being part of an index
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Moderna, Inc. (MRNA) Price to free cash flow

Moderna, Inc. has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 109× (December 2020) — the current reading is the lowest in ten years.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 15.4× 100.58%
FY2021 7.7× (62.23%)
FY2020 20.3× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period Price to free cash flow Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
30 more quarters

Against its own ten years

Low 0.0× High 109×
Ten-year median 0.0×
Current reading's percentile 65

Price to free cash flow against peers

Company Price to free cash flow
INSM Insmed, Inc. compare n/m
RVMD Revolution Medicines, Inc. compare n/m
MRNA Moderna, Inc. n/m
RPRX Royalty Pharma PLC compare 19.8×
REGN Regeneron Pharmaceuticals, Inc. compare 22.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 30.7×
VRTX Vertex Pharmaceuticals Incorporated compare 35.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 41.7×
ARGX argenex SE compare 43.4×
Biotechnology industry median 21.2×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on MRNA